F94L (p.Phe94Leu) variant of KRT16 (Keratin, type I cytoskeletal 16)

F94L (p.Phe94Leu) in KRT16 (Keratin, type I cytoskeletal 16) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.

F94L (p.Phe94Leu) variant details